REVIVA PHARMACEUTICALS HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.99 USD | +0.34% |
|
-0.99% | -41.94% |
Chart calendar Reviva Pharmaceuticals Holdings, Inc.
e.IN0Ui2C0zRCkWzsZE2yB9FpNX_etjkppm3C-aO7UL5I.F6hTvyj5r3bSDFxuVV7JnjQuDLPUozoo6gnoMd7gY951iHW-KMaqIOo-XA~0dc20c5f28ad7f8fa21038a709faef1b
Upcoming events on Reviva Pharmaceuticals Holdings, Inc.
Past events on Reviva Pharmaceuticals Holdings, Inc.
| 15/04/2024 05:35 pm | Q4 2023 Earnings Release |
| 04/04/2024 03:30 pm | Schizophrenia International Research Society Meeting - Poster No : T291 |
| 04/04/2024 01:55 pm | Schizophrenia International Research Society Meeting |
| 28/03/2024 04:30 am | American Society for Clinical Pharmacology & Therapeutics Meeting |
| 20/03/2024 02:30 am | Roth Conference |
| 18/03/2024 11:00 pm | UBS Virtual CNS Day |
| 27/02/2024 01:15 am | BIO CEO & Investor Conference |
| 15/02/2024 10:30 pm | Investor Meeting - key Opinion Leader |
| 01/02/2024 11:00 pm | Lytham Partners Investor Select Conference - Fireside Chat |
| 18/01/2024 01:30 am | Webull Live Virtual Healthcare Investment Conference |
| 14/12/2023 10:30 pm | Life Sciences Investor Forum |
| 07/12/2023 | Benchmark Company Discovery Conference |
| 15/11/2023 02:31 am | Q3 2023 Earnings Release |
| 14/11/2023 12:30 am | Annual General Meeting |
| 30/10/2023 06:00 pm | Phase 3 RECOVER Topline Results Conference Call |
| 13/09/2023 01:00 am | H.C. Wainwright Global Investment Conference - Panel |
| 11/09/2023 11:00 pm | H.C. Wainwright Global Investment Conference |
| 15/08/2023 01:31 am | Q2 2023 Earnings Release |
| 10/08/2023 07:30 pm | Canaccord Genuity Growth Conference |
| 08/08/2023 11:30 pm | BTIG Virtual Biotechnology Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -2,43 -2,33 -4.54% | -10,1 -10,4 3.12% | -24,3 -21,0 -15.56% | -39,5 -38,6 -2.22% | -39,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,78 -2,80 -35.14% | -8,52 -9,15 6.97% | -24,3 -20,8 -16.96% | -39,2 -37,5 -4.64% | -37,1 |
|
Net income Million USD | Released Forecast Spread | -3,78 -2,80 -35.12% | -8,52 -9,16 6.98% | -24,3 -20,9 -16.41% | -39,3 -38,6 -1.75% | -37,1 |
|
EPS USD | Released Forecast Spread | -1,24 -0,17 -629.41% | -0,58 -0,63 8.42% | -1,25 -1,09 -14.94% | -1,65 -1,58 -4.21% | -1,24 |
| Announcement Date | 22/03/21 | 15/03/22 | 30/03/23 | 15/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -3,96 -4,03 1.67% | -7,45 -4,49 -66.02% | -5,52 -6,64 16.85% | -3,56 -5,76 38.16% | -7,77 -4,50 -72.73% | -6,74 -7,35 8.4% | -12,1 -6,54 -84.51% | -10,7 -8,78 -22.01% | -9,99 -9,14 -9.33% | -10,1 | -9,85 | -10,8 | -12,1 | -13,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,68 -4,32 14.79% | -7,36 -4,49 -64.04% | -5,33 -6,64 19.65% | -3,51 -5,84 39.86% | -8,11 -4,33 -87.11% | -6,60 -7,30 9.63% | -12,4 -6,41 -94.1% | -10,5 -7,99 -31.09% | -9,73 -7,99 -21.71% | -10,2 | -9,93 | -10,8 | -12,1 | -13,6 |
|
Net income Million USD | Released Forecast Spread | -3,68 -4,33 14.8% | -7,37 -4,49 -64.09% | -5,34 -6,64 19.54% | -3,52 -5,84 39.83% | -8,12 -4,33 -87.3% | -6,60 -7,30 9.59% | -12,4 -6,41 -94.16% | -10,5 -8,00 -31.21% | -9,72 -8,00 -21.63% | -10,2 | -9,93 | -10,8 | -12,1 | -13,6 |
|
EPS USD | Released Forecast Spread | -0,22 -0,25 12% | -0,40 -0,25 -60% | -0,29 -0,35 17.14% | -0,18 -0,30 40% | -0,38 -0,22 -75.38% | -0,30 -0,31 1.64% | -0,55 -0,29 -89.66% | -0,44 -0,32 -36.65% | -0,35 -0,31 -12.9% | -0,37 | -0,35 | -0,36 | -0,38 | -0,42 |
| Announcement Date | 15/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 30/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | 15/04/24 | - | - | - | - | - |
More events
Past sector events for Reviva Pharmaceuticals Holdings, Inc.
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RVPH Stock
- Calendar Reviva Pharmaceuticals Holdings, Inc.
